Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell TransplantationMatthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Pancreas|May 13, 2016
Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II TrialsPamela L Kunz, Raymond R Balise, Louis Fehrenbacher, et al.
Investigational New Drugs|November 11, 2019
A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancerJohanna C Bendell, Helge G Bischoff, Jimmy Hwang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2021
DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled StudyRoy F Chemaly, Francisco M Marty, Cameron R Wolfe, et al.
Journal of Geriatric Oncology|June 5, 2014
Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipientsJesse W Keller, Charalambos Andreadis, Lloyd E Damon, et al.
Liver Cancer|December 24, 2021
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation ProfilingRobin K Kelley, Nancy M Joseph, Halla S Nimeiri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2014
Circulating tumor cell analysis in metastatic triple-negative breast cancersMark Jesus M Magbanua, Lisa A Carey, Amy DeLuca, et al.
BMC Cancer|April 18, 2015
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controlsRobin K Kelley, Mark Jesus M Magbanua, Timothy M Butler, et al.
The Oncologist|March 6, 2019
First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced CancerAiwu Ruth He, Roger B Cohen, Crystal S Denlinger, et al.
Cancer Chemotherapy and Pharmacology|January 7, 2017
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation studyJohn Sarantopoulos, Alain C Mita, Aiwu He, et al.
Pageof 9